Johnson & Johnson
JNJ US4781601046
Johnson Johnson is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange. Its common stock is a component of the Dow Jones Industrial Average, and the company is ranked No. 40 on the 2023 Fortune 500 list of the largest United States corporations. In 2023, the company was ranked 40th in the Forbes Global 2000. Johnson Johnson has a global workforce of approximately 130,000 employees who are led by the companys current chairman and chief executive officer, Joaquin Duato.
Annual Performance 1
2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
12% | 6% | -9% | -7% | 0% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Person | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Taubert Jennifer L EX VP |
177.81 USD |
56,471 Sold |
10,040,883 USD |
04/09/2025 | 04/09/2025 |
Duato Joaquin CEO |
179.21 USD |
125,824 Sold |
22,548,655 USD |
22/08/2025 | 22/08/2025 |
Wolk Joseph J EX VP |
176.91 USD |
16,820 Sold |
2,975,571 USD |
15/08/2025 | 15/08/2025 |
Reed John C EX VP |
163.55 USD |
19,137 Sold |
3,129,830 USD |
17/07/2025 | 17/07/2025 |
Decker Robert J VP |
165.88 USD |
6,999 Sold |
1,160,994 USD |
25/02/2025 | 25/02/2025 |
Schmid Timothy EX VP |
156.15 USD |
403 Sold |
62,928 USD |
13/02/2025 | 18/02/2025 |
Wolk Joseph J EX VP |
153.89 USD |
13,015 Sold |
2,002,878 USD |
07/02/2025 | 07/02/2025 |
Weinberger Mark A |
147.22 USD |
1,000 Bought |
147,220 USD |
12/12/2024 | 12/12/2024 |
Decker Robert J VP |
165.06 USD |
5,635 Sold |
930,113 USD |
30/08/2024 | 30/08/2024 |
Broadhurst Vanessa EX VP |
162.16 USD |
8,891 Sold |
1,441,765 USD |
13/03/2024 | 13/03/2024 |